Skip to main content

Table 2 Cardiovascular comorbidities and cancer therapy with cardiotoxicity potential among post-treatment cancer survivors (N = 502)

From: Cardiovascular health assessment in routine cancer follow-up in community settings: survivor risk awareness and perspectives

Cardiovascular Comorbidities

N

%

 High Cholesterol1

241

48.3

 Hypertension or high BP

240

47.8

 Obesity2

166

33.1

 Diabetes

103

20.5

 Atherosclerotic Vascular Disease (ASCVD)2**

67

13.4

 Heart Failure

15

3.0

Receipt of Cancer Treatment with High Cardiotoxicity Potential***

153

30.5

1n=499; 2n=501

  1. **ASCVD includes Heart Disease, Peripheral Vascular Disease, Myocardial Infarction, and Cerebrovascular Disease
  2. ***classified according to Herrmann 2020 [36]
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us